KEGG   PATHWAY: oda04920
Entry
oda04920                    Pathway                                
Name
Adipocytokine signaling pathway - Oryx dammah (scimitar-horned oryx)
Description
Increased adipocyte volume and number are positively correlated with leptin production, and negatively correlated with production of adiponectin.
Leptin is an important regulator of energy intake and metabolic rate primarily by acting at hypothalamic nuclei. Leptin exerts its anorectic effects by modulating the levels of neuropeptides such as NPY, AGRP, and alpha-MSH. This leptin action is through the JAK kinase, STAT3 phosphorylation, and nuclear transcriptional effect.
Adiponectin lowers plasma glucose and FFAs. These effects are partly accounted for by adiponectin-induced AMPK activation, which in turn stimulates skeletal muscle fatty acid oxidation and glucose uptake. Furthermore, activation of AMPK by adiponectin suppresses endogenous glucose production, concomitantly with inhibition of PEPCK and G6Pase expression.
The proinflammatory cytokine TNFalpha has been implicated as a link between obesity and insulin resistance. TNFalpha interferes with early steps of insulin signaling. Several data have shown that TNFalpha inhibits IRS1 tyrosine phosphorylation by promoting its serine phosphorylation. Among the serine/threonine kinases activated by TNFalpha, JNK, mTOR and IKK have been shown to be involved in this phosphorylation.
Class
Organismal Systems; Endocrine system
Pathway map
oda04920  Adipocytokine signaling pathway
oda04920

Organism
Oryx dammah (scimitar-horned oryx) [GN:oda]
Gene
120870534  TNF; tumor necrosis factor [KO:K03156]
120858711  TNFRSF1A; tumor necrosis factor receptor superfamily member 1A [KO:K03158]
120872773  TRADD; tumor necrosis factor receptor type 1-associated DEATH domain protein [KO:K03171]
120880236  TNFRSF1B; tumor necrosis factor receptor superfamily member 1B isoform X1 [KO:K05141]
120852193  TRAF2; TNF receptor-associated factor 2 isoform X1 [KO:K03173] [EC:2.3.2.27]
120880214  MTOR; serine/threonine-protein kinase mTOR [KO:K07203] [EC:2.7.11.1]
120861535  MAPK10; mitogen-activated protein kinase 10 isoform X1 [KO:K04440] [EC:2.7.11.24]
120864358  MAPK9; mitogen-activated protein kinase 9 isoform X1 [KO:K04440] [EC:2.7.11.24]
120865345  MAPK8; mitogen-activated protein kinase 8 isoform X1 [KO:K04440] [EC:2.7.11.24]
120873530  CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1 [KO:K04467] [EC:2.7.11.10]
120865846  IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1 [KO:K07209] [EC:2.7.11.10]
120881825  IKBKG; NF-kappa-B essential modulator isoform X1 [KO:K07210]
120875083  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
120872421  NFKBIB; NF-kappa-B inhibitor beta [KO:K02581]
120870082  NFKBIE; NF-kappa-B inhibitor epsilon [KO:K05872]
120861869  NFKB1; nuclear factor NF-kappa-B p105 subunit isoform X1 [KO:K02580]
120874649  RELA; transcription factor p65 [KO:K04735]
120866823  SOCS3; suppressor of cytokine signaling 3 [KO:K04696]
120854447  IRS1; insulin receptor substrate 1 [KO:K16172]
120883252  IRS2; insulin receptor substrate 2 [KO:K07187]
120879389  insulin receptor substrate 1-like [KO:K17445]
120881381  IRS4; insulin receptor substrate 4 [KO:K17446]
120880303  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
120875130  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
120872394  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
120878121  platelet glycoprotein 4-like [KO:K06259]
120878122  LOW QUALITY PROTEIN: platelet glycoprotein 4-like [KO:K06259]
120878123  platelet glycoprotein 4 [KO:K06259]
120881386  ACSL4; long-chain-fatty-acid--CoA ligase 4 isoform X1 [KO:K01897] [EC:6.2.1.3]
120854467  ACSL3; long-chain-fatty-acid--CoA ligase 3 [KO:K01897] [EC:6.2.1.3]
120864732  ACSL6; long-chain-fatty-acid--CoA ligase 6 isoform X1 [KO:K01897] [EC:6.2.1.3]
120865725  ACSL1; long-chain-fatty-acid--CoA ligase 1 isoform X1 [KO:K01897] [EC:6.2.1.3]
120873899  ACSL5; long-chain-fatty-acid--CoA ligase 5 isoform X1 [KO:K01897] [EC:6.2.1.3]
120875508  ACSBG1; long-chain-fatty-acid--CoA ligase ACSBG1 isoform X1 [KO:K15013] [EC:6.2.1.3]
120864877  ACSBG2; long-chain-fatty-acid--CoA ligase ACSBG2 [KO:K15013] [EC:6.2.1.3]
120869142  PRKCQ; protein kinase C theta type [KO:K18052] [EC:2.7.11.13]
120877318  leptin [KO:K05424]
120857031  LEPR; leptin receptor isoform X1 [KO:K05062]
120860228  tyrosine-protein kinase JAK2-like isoform X1 [KO:K04447] [EC:2.7.10.2]
120865363  JAK2; tyrosine-protein kinase JAK2 isoform X1 [KO:K04447] [EC:2.7.10.2]
120867076  STAT3; signal transducer and activator of transcription 3 isoform X1 [KO:K04692]
120851603  POMC; pro-opiomelanocortin [KO:K05228]
120872750  agouti-related protein [KO:K05231]
120877451  NPY; pro-neuropeptide Y [KO:K05232]
120861984  PPARGC1A; peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X1 [KO:K07202]
120853458  PCK2; phosphoenolpyruvate carboxykinase [GTP], mitochondrial [KO:K01596] [EC:4.1.1.32]
120869363  PCK1; phosphoenolpyruvate carboxykinase, cytosolic [GTP] isoform X1 [KO:K01596] [EC:4.1.1.32]
120867120  G6PC1; glucose-6-phosphatase isoform X1 [KO:K01084] [EC:3.1.3.9]
120854888  G6PC2; glucose-6-phosphatase 2 [KO:K01084] [EC:3.1.3.9]
120867042  G6PC3; glucose-6-phosphatase 3 isoform X1 [KO:K01084] [EC:3.1.3.9]
120871132  PTPN11; tyrosine-protein phosphatase non-receptor type 11 isoform X1 [KO:K07293] [EC:3.1.3.48]
120880615  tyrosine-protein phosphatase non-receptor type 11-like isoform X1 [KO:K07293] [EC:3.1.3.48]
120858467  PPARA; peroxisome proliferator-activated receptor alpha [KO:K07294]
120852176  RXRA; retinoic acid receptor RXR-alpha [KO:K08524]
120869850  RXRB; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
120855496  RXRG; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
120872466  ADIPOQ; adiponectin isoform X1 [KO:K07296]
120880093  ADIPOR1; adiponectin receptor protein 1 isoform X1 [KO:K07297]
120857843  ADIPOR2; adiponectin receptor protein 2 isoform X1 [KO:K07297]
120867954  APPL1; DCC-interacting protein 13-alpha [KO:K08733]
120863710  STK11; serine/threonine-protein kinase STK11 isoform X1 [KO:K07298] [EC:2.7.11.1]
120871048  CAMKK2; calcium/calmodulin-dependent protein kinase kinase 2 isoform X1 [KO:K07359] [EC:2.7.11.17]
120879416  PRKAA1; 5'-AMP-activated protein kinase catalytic subunit alpha-1 isoform X1 [KO:K07198] [EC:2.7.11.31]
120856086  PRKAA2; 5'-AMP-activated protein kinase catalytic subunit alpha-2 isoform X1 [KO:K07198] [EC:2.7.11.31]
120871110  PRKAB1; 5'-AMP-activated protein kinase subunit beta-1 [KO:K07199]
120855986  PRKAB2; 5'-AMP-activated protein kinase subunit beta-2 [KO:K07199]
120877947  PRKAG2; 5'-AMP-activated protein kinase subunit gamma-2 isoform X1 [KO:K07200]
120861280  5'-AMP-activated protein kinase subunit gamma-1 [KO:K07200]
120854364  PRKAG3; 5'-AMP-activated protein kinase subunit gamma-3 isoform X1 [KO:K07200]
120858195  5'-AMP-activated protein kinase subunit gamma-1 [KO:K07200]
120871398  ACACB; acetyl-CoA carboxylase 2 [KO:K01946] [EC:6.4.1.2 6.3.4.14 2.1.3.15]
120874135  CPT1A; carnitine O-palmitoyltransferase 1, liver isoform [KO:K08765] [EC:2.3.1.21]
120857792  CPT1B; carnitine O-palmitoyltransferase 1, muscle isoform isoform X1 [KO:K19523] [EC:2.3.1.21]
120872120  CPT1C; carnitine O-palmitoyltransferase 1, brain isoform isoform X1 [KO:K19524] [EC:2.3.1.21]
120856308  SLC2A1; solute carrier family 2, facilitated glucose transporter member 1 [KO:K07299]
120866070  SLC2A4; solute carrier family 2, facilitated glucose transporter member 4 [KO:K07191]
Compound
C00040  Acyl-CoA
C00076  Calcium cation
C00083  Malonyl-CoA
C00162  Fatty acid
C00165  Diacylglycerol
C00195  N-Acylsphingosine
C00638  Long-chain fatty acid
C15493  9-cis-Retinoic acid
Reference
  Authors
Gual P, Le Marchand-Brustel Y, Tanti JF.
  Title
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
  Journal
Biochimie 87:99-109 (2005)
DOI:10.1016/j.biochi.2004.10.019
Reference
  Authors
Hardie DG, Scott JW, Pan DA, Hudson ER.
  Title
Management of cellular energy by the AMP-activated protein kinase system.
  Journal
FEBS Lett 546:113-20 (2003)
DOI:10.1016/S0014-5793(03)00560-X
Reference
  Authors
Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA.
  Title
The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases.
  Journal
J Biol Chem 280:29060-6 (2005)
DOI:10.1074/jbc.M503824200
Reference
  Authors
Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG.
  Title
Central nervous system control of food intake.
  Journal
Nature 404:661-71 (2000)
DOI:10.1038/35007534
Reference
  Authors
Munzberg H, Myers MG Jr.
  Title
Molecular and anatomical determinants of central leptin resistance.
  Journal
Nat Neurosci 8:566-70 (2005)
DOI:10.1038/nn1454
Reference
  Authors
Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM.
  Title
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.
  Journal
Nature 423:550-5 (2003)
DOI:10.1038/nature01667
Reference
  Authors
Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM.
  Title
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.
  Journal
Nature 413:131-8 (2001)
DOI:10.1038/35093050
Reference
  Authors
Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, LeRoith D, Takeda K, Akira S, Kasuga M.
  Title
Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo.
  Journal
Nat Med 10:168-74 (2004)
DOI:10.1038/nm980
Reference
PMID:9671776
  Authors
Zhou YT, Shimabukuro M, Wang MY, Lee Y, Higa M, Milburn JL, Newgard CB, Unger RH.
  Title
Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells.
  Journal
Proc Natl Acad Sci U S A 95:8898-903 (1998)
DOI:10.1073/pnas.95.15.8898
Reference
  Authors
Kelley DE, Mandarino LJ.
  Title
Fuel selection in human skeletal muscle in insulin resistance: a reexamination.
  Journal
Diabetes 49:677-83 (2000)
DOI:10.2337/diabetes.49.5.677
Reference
  Authors
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T.
  Title
Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.
  Journal
Nat Med 8:1288-95 (2002)
DOI:10.1038/nm788
Reference
  Authors
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T.
  Title
The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.
  Journal
Nat Med 7:941-6 (2001)
DOI:10.1038/90984
Reference
  Authors
Minokoshi Y, Alquier T, Furukawa N, Kim YB, Lee A, Xue B, Mu J, Foufelle F, Ferre P, Birnbaum MJ, Stuck BJ, Kahn BB.
  Title
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.
  Journal
Nature 428:569-74 (2004)
DOI:10.1038/nature02440
Reference
  Authors
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr.
  Title
Obesity is associated with macrophage accumulation in adipose tissue.
  Journal
J Clin Invest 112:1796-808 (2003)
DOI:10.1172/JCI19246
Related
pathway
oda04010  MAPK signaling pathway
oda04910  Insulin signaling pathway
KO pathway
ko04920   
LinkDB

DBGET integrated database retrieval system